Evidence continues to mount
A research study published Sept. 17 by Correlation
Research in the Public Interest, “COVID-19 vaccine associated mortality in the Southern Hemisphere,” examined the vaccine-dose fatality rate for all ages.
Researchers assessed all-cause mortality in 17 countries and found COVID-19 vaccines did not have any beneficial effect on reducing overall mortality.
The researchers did find however that unexpected peaks in high all-cause mortality in each country—especially among the elderly population when COVID-19 vaccines were deployed—coincided with the rollout of third and fourth booster doses.
“This would correspond to a mass iatrogenic event that killed (0.213 ± 0.006) % of the world population (1 death per 470 living persons, in less than 3 years), and did not measurably prevent any deaths,” the authors said.
The researchers conducted an analysis of all-cause mortality using data from the World Mortality Dataset for 17 equatorial and Southern Hemisphere countries, including Argentina, Australia, Bolivia, Brazil, Chile, Colombia, Ecuador, Malaysia, New Zealand, Paraguay, Peru, Philippines, Singapore, South Africa, Suriname, Thailand, and Uruguay. Equatorial countries have no summer and winter seasons, so there are no seasonal variations in their all-cause mortality patterns.
Key findings from the 180-page report include:
• In all countries included in the analysis, all-cause mortality increased when COVID-19 vaccines were deployed.
• Nine of 17 countries had no detectable excess deaths following the World Health Organization’s March 11, 2020, declaration of the pandemic until the beginning of the COVID-19 vaccination campaign.
• Unprecedented peaks in all-cause mortality were observed in January and February 2022, during the summer season of Southern Hemisphere countries coinciding with or following the rollout of boosters in 15 of 17 countries studied.
• Excess all-cause mortality during the vaccination period beginning January 2021 was 1.74 million deaths, or one death per 800 injections, in the 17 countries studied.
By examining mortality and vaccination data from Chile and Peru by age and dose number, researchers observed clear peaks in all-cause mortality in July through August 2021, January through February 2022, and July through August 2022 among elderly age groups. The increase in all-cause mortality observed in January and February 2022 in both countries coincided with the rapid rollout of Chile’s fourth COVID-19 vaccine dose and Peru’s third dose.
It is unlikely that the rise in all-cause mortality coinciding with the rollout and sustained administration of COVID-19 vaccines in all 17 countries could be due to any cause other than the vaccines, researchers said.
“There is no evidence in the hard data of all-cause mortality of a beneficial effect from the COVID-19 vaccine rollouts. No lives were saved,” Denis Rancourt, co-director of Correlation Research in the Public Interest with a doctorate in physics, told Epoch Times. “On the contrary, the evidence can be understood in terms of being subjected to a toxic substance. The risk of death per injection increases exponentially with age. The policy of prioritizing the elderly for injection must be ended immediately.”
All Correlations reports and this study can be found at https://correlation-canada.org/research/